Editas Medicine (NQ: EDIT )

33.22 USD +1.82 (+5.80%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2021 Add to My Watchlist

Price and Volume

Volume	1,428,153
Open	31.75
Bid (Size)	33.55 (1)
Ask (Size)	33.88 (2)
Prev. Close	31.40
Today's Range	31.58 - 33.42
52wk Range	24.47 - 99.95
Shares Outstanding	67,826,436
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Editas Medicine Announces First Quarter 2021 Results and Update

May 05, 2021

Editas Medicine Names Mark S. Shearman, Ph.D., as Chief Scientific Officer

May 05, 2021

Performance

YTD	-53.60%	-53.60%
1 Month	-18.94%	-18.94%
3 Month	-41.15%	-41.15%
6 Month	+14.32%	+14.32%
1 Year	+26.41%	+26.41%

More News

Editas Medicine to Present Preclinical Data Demonstrating Progress in Development of Gene Editing Medicines for the Treatment of Genetic Ocular Diseases at the American Society of Gene and Cell Therap

May 04, 2021

Editas Medicine to Present Preclinical Data Demonstrating Advancements in In Vivo Gene Editing Approach for the Treatment of Genetic Ocular Diseases at the Association for Research in Vision and Ophth

May 01, 2021

Noteworthy Friday Option Activity: WDC, EDIT, CRMD

May 14, 2021

Editas Medicine to Host Conference Call Discussing First Quarter 2021 Results and Corporate Update

April 28, 2021

First Week of June 18th Options Trading For Editas Medicine (EDIT)

May 11, 2021

11 Plunging Stocks Are Badly Burning Cathie Wood's ARK Invest

May 11, 2021

With 1 Cure Behind It, This Breakthrough Biotech Takes Aim at a Bigger Market

May 07, 2021

Notable Tuesday Option Activity: AAWW, EDIT, AKAM

May 04, 2021

Editas Medicine, Inc. (EDIT) Q1 2021 Earnings Call Transcript

May 05, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.